Roivant Sciences Ltd. (ROIV)

Roivant Sciences Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	1,959	6,536	1,677	2,060	2,055	2,183
Cash & Short-Term Investments	5,387	6,536	1,677	2,060	2,055	2,183
Cash Growth	282.51%	289.77%	-18.62%	0.26%	-5.87%	157.19%
Accounts Receivable	1.92	53.55	30.38	3.88	-	3.67
Other Receivables	20.77	29.27	7.27	2.85	-	6.61
Receivables	22.68	82.81	37.64	6.73	-	15.28
Inventory	-	35.25	2.76	-	-	-
Prepaid Expenses	54.84	55.1	60.83	53.37	-	16.34
Restricted Cash	3.11	5.37	5.01	3.9	77.7	2.28
Other Current Assets	333.83	17.6	15.53	22.12	54.25	2.14
Total Current Assets	5,801	6,732	1,799	2,147	2,187	2,219
Property, Plant & Equipment	56.65	65.95	92.34	86.95	77.03	73.93
Long-Term Investments	311.35	247.75	304.32	325.83	289.54	93.45
Other Intangible Assets	-	137.84	144.88	-	-	-
Other Long-Term Assets	36.9	39.11	49.48	25.82	36.13	90.43
Total Assets	6,206	7,222	2,390	2,585	2,590	2,477
Accounts Payable	25.13	53.23	37.83	34.58	20.55	10.31
Accrued Expenses	111.47	175.59	167.13	127.53	76.94	68.62
Current Portion of Long-Term Debt	-	12	40.72	-	-	-
Current Portion of Leases	9.52	9.89	11.69	11.4	12.31	7.84
Current Income Taxes Payable	5.41	10.47	0.54	0.71	-	1.5
Current Unearned Revenue	3.41	4.17	12.44	10.15	5.92	3.62
Other Current Liabilities	401.31	1.42	2.09	-	103.24	0.23
Total Current Liabilities	556.25	266.76	272.45	184.37	218.96	92.12
Long-Term Debt	-	430.59	375.52	210.03	170.28	108.59
Long-Term Leases	43.19	47.27	53.48	62.47	62.38	64.45
Other Long-Term Liabilities	26.55	29.34	80.58	66.84	76.06	103.19
Total Liabilities	625.99	773.95	782.02	523.7	527.69	368.36
Additional Paid-In Capital	4,775	5,396	4,933	4,422	3,815	3,144
Retained Earnings	395.58	576.17	-3,773	-2,764	-1,918	-1,109
Comprehensive Income & Other	-18.04	-4.08	-2.62	-0.95	-98.56	-2.35
Total Common Equity	5,153	5,969	1,158	1,657	1,798	2,032
Minority Interest	427.09	479.95	449.82	404.49	264.22	76.53
Shareholders' Equity	5,580	6,449	1,608	2,061	2,062	2,109
Total Liabilities & Equity	6,206	7,222	2,390	2,585	2,590	2,477
Total Debt	52.71	499.75	481.4	283.89	244.98	180.88
Net Cash (Debt)	5,334	6,036	1,195	1,777	1,810	2,002
Net Cash Growth	485.98%	404.93%	-32.71%	-1.85%	-9.60%	183.74%
Net Cash Per Share	6.53	7.26	1.68	2.65	2.87	9.14
Filing Date Shares Outstanding	727.95	738.72	766.81	700.77	222.67	214.88
Total Common Shares Outstanding	733.33	806.68	760.14	694.98	222.67	214.88
Working Capital	5,245	6,465	1,526	1,962	1,968	2,127
Book Value Per Share	7.03	7.40	1.52	2.38	8.07	9.46
Tangible Book Value	5,153	5,831	1,013	1,657	1,798	2,032
Tangible Book Value Per Share	7.03	7.23	1.33	2.38	8.07	9.46

Source: S&P Capital IQ. Standard template. Financial Sources.